Global Leading Market Research Publisher QYResearch announces the release of its latest report *“Hard Empty Nutraceutical Capsules – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”*. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Hard Empty Nutraceutical Capsules market, including market size, share, demand, industry development status, and forecasts for the next few years.
Nutraceutical formulators and dietary supplement manufacturers face a persistent challenge: identifying encapsulation solutions that protect sensitive active ingredients (probiotics, botanical extracts, omega-3 oils) from degradation while enabling precise dosing, scalable production, and targeted release profiles. Hard Empty Nutraceutical Capsules address these requirements through rigid hollow shells made from gelatin or plant-based materials (HPMC, pullulan), offering superior chemical stability, mechanical strength, and protection against light, moisture, and oxidation compared to soft capsules. This report analyzes market dynamics across dosage sizes (00#, 0#, 1#, 2#, 3#), material types (gelatin vs. plant-based), release mechanisms (immediate, sustained, enteric-coated), and end-user segments (pharmaceuticals, health supplements), delivering actionable intelligence for strategic sourcing and formulation decisions.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/4946348/hard-empty-nutraceutical-capsules
Market Sizing and Growth Trajectory (2024-2031)
The global market for Hard Empty Nutraceutical Capsules was estimated to be worth US$ 2,515 million in 2024 and is forecast to a readjusted size of US$ 3,786 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031. Hard empty nutraceutical capsules are rigid hollow capsules made from gelatin, hydroxypropyl methylcellulose (HPMC), or other edible plant-based polysaccharides, specifically designed to encapsulate dietary supplements, vitamins, minerals, botanical extracts, and other functional nutritional ingredients. Compared with soft capsules, hard empty capsules offer superior chemical stability and mechanical strength, effectively protecting active ingredients from light, moisture, and oxidation, while allowing precise dosing and large-scale manufacturing. Depending on formulation requirements, hard empty capsules can be designed as immediate-release, sustained-release, or enteric-coated forms to achieve targeted release locations and timing, making them widely used in the dietary supplement and functional food sectors. In 2024, the global sales volume of hard empty nutraceutical capsules reached 1.04 trillion capsules, with an average price of USD 24 per 10,000 capsules.
Supply Chain Deep-Dive: Manufacturing Differentiation (Discrete vs. Process)
A critical industry distinction emerges when examining discrete manufacturing (capsule filling, sealing, and packaging) versus process manufacturing (shell formation via dip coating, drying, and stripping). Hard empty capsule shell production exemplifies process manufacturing: stainless steel pins are dipped into temperature-controlled gelatin or HPMC solutions (typically 50-60°C), rotated for uniform coating thickness, dried in controlled humidity chambers (30-40% RH), stripped, cut, and joined. This continuous process requires precise viscosity control (2,000-5,000 cP) and drying air velocity (0.5-1.5 m/s) to achieve consistent shell thickness (±0.05mm) and mechanical strength.
In contrast, downstream nutraceutical manufacturing follows discrete manufacturing principles: capsule filling machines meter precise powder or liquid formulations into empty shells, followed by sealing (banding or locking), counting, and blister or bottle packaging. This bifurcation creates distinct quality control parameters: shell manufacturers focus on disintegration time (typically <15 minutes for gelatin, <30 minutes for HPMC) and moisture content (13-16% for gelatin, 3-7% for HPMC), while fillers prioritize fill weight uniformity (±3-5%) and content uniformity across batch sizes exceeding 1 million capsules.
Recent Industry Data (Last 6 Months)
- May 2025: Lonza announced a $150 million expansion of its HPMC capsule manufacturing facility in Greenwood, South Carolina, increasing annual capacity by 35 billion capsules to meet growing demand for plant-based, vegan-certified nutraceutical encapsulation.
- February 2025: The European Commission published new guidance on enteric-coated hard capsules for probiotic delivery, requiring demonstrated survival rates >70% through simulated gastric fluid (pH 1.2 for 2 hours) for any products making gut-health claims.
- Market dynamic: The Asia-Pacific hard empty nutraceutical capsule market grew 8.9% YoY in 2024 (vs. global 6.1%), driven by Chinese manufacturers (Shandong Healsee, Anhui Huangshan, Zhejiang Yueshan) capturing increased export share to Southeast Asian supplement brands seeking cost-effective encapsulation solutions.
Typical User Cases and Technical Challenges
- Case 1 (Probiotics – Enteric Protection): A US-based probiotic manufacturer formulated a multi-strain product (Lactobacillus and Bifidobacterium, 50 billion CFU) using enteric-coated hard empty capsules (size 0#, HPMC-based). Accelerated stability testing (40°C/75% RH for 6 months) demonstrated 92% viability retention versus 67% for standard gelatin capsules. The enteric coating (Eudragit L30D-55) enabled targeted release in the small intestine (pH >5.5), bypassing gastric acid degradation—a critical technical requirement for live biotherapeutic products.
- Case 2 (Botanical Extract – Sustained Release): A German nutraceutical company developed a sustained-release curcumin formulation using hard empty capsules filled with lipid-coated extract particles. The capsule shell (size 1#, gelatin) incorporated a hydroxypropyl methylcellulose (HPMC) matrix that extended release over 8 hours (85% released at 8 hours vs. 95% at 2 hours for immediate-release). Clinical testing (n=45 subjects) showed 3.2x higher 12-hour plasma curcuminoid levels compared to standard formulation, enabling once-daily dosing for joint health applications.
- Technical Hurdle: Cross-linking of gelatin capsules (due to aldehydes from reactive fill formulations) can reduce dissolution rates by 40-60%, causing delayed or incomplete drug release. Manufacturers like ACG Associated Capsules and Suheung have developed low-moisture gelatin formulations (8-10% water content) and aldehyde-scavenging excipients (glycine, lysine) to mitigate this issue, though at 8-12% cost premium.
Policy and Regulatory Update (2024-2025)
- The US FDA published a draft guidance (March 2025) on the use of titanium dioxide alternatives (calcium carbonate, talc) in hard capsule shells, following the EU’s titanium dioxide ban (effective August 2024). Manufacturers must requalify opacity and UV protection properties for light-sensitive fills.
- China’s State Administration for Market Regulation (SAMR) revised its “Regulations on Health Food Filing” (January 2025), reducing documentation requirements for hard empty capsules made from established materials (gelatin, HPMC) while maintaining strict heavy metal limits (lead <1.5 ppm, arsenic <1.0 ppm).
- India’s FSSAI approved HPMC capsules for Ayurvedic and herbal supplement applications (December 2024), previously restricted to gelatin-based shells, opening a significant market for plant-based capsule suppliers.
Dosage Size Segmentation and Application Matching
The Hard Empty Nutraceutical Capsules market is segmented by size, with each size serving distinct fill volumes and patient populations:
- 00# (largest, 0.91-0.95mL fill volume): Preferred for high-dose botanical extracts and combination supplements (e.g., multivitamins with minerals)
- 0# (0.68-0.72mL): Most common size for pharmaceutical-grade nutraceuticals and single-ingredient supplements
- 1# (0.48-0.50mL): Dominant size for pediatric supplements and geriatric formulations (easier swallowing)
- 2# (0.36-0.38mL): Growing segment for low-dose actives (e.g., vitamin D3, CoQ10)
- 3# (0.27-0.30mL): Specialized applications requiring very small fill volumes
- Others (4#, 5#, proprietary sizes): Niche applications including clinical trial materials and veterinary supplements
独家观察 / Exclusive Insight: Industry Stratification by Material and Geography
A clear market stratification is emerging across capsule materials and geographic regions. Gelatin-based hard capsules (approx. 68% of global volume in 2024) dominate pharmaceutical applications and traditional supplement markets, particularly in North America and Europe, where cost sensitivity and established supply chains favor this material. Plant-based HPMC capsules (approx. 29% of volume, growing at 9.8% CAGR vs. 4.9% for gelatin) are capturing share in vegan-labeled products, clean-label supplements, and Muslim-majority markets (halal certification), led by Lonza (Capsugel brand) and ACG Associated Capsules.
Geographically, China accounts for 38% of global production capacity but only 22% of premium HPMC capsule output, as domestic manufacturers (Anhui Huangshan, Zhejiang Tianlong) primarily serve regional gelatin capsule markets. Japanese manufacturers (Qualicaps) and European producers (Suheung, CapsCanada) dominate the high-value enteric-coated and sustained-release segments, leveraging proprietary polymer technologies and regulatory expertise. By 2028, the plant-based capsule segment is projected to reach 38% market share, driven by accelerating consumer preference for vegan and vegetarian supplements and regulatory approvals for HPMC in emerging markets. Notably, Qingdao Gather Great Ocean Algae Industry Group has commercialized algae-derived polysaccharide capsules (patented technology), offering a third material category with oxygen barrier properties superior to both gelatin and HPMC—potentially disrupting the premium encapsulation segment.
The Hard Empty Nutraceutical Capsules market is segmented as below:
Qualicaps
Lonza
ACG Associated Capsules
Suheung
CapsCanada
Sunil Healthcare
Evonik Specialty Chemicals
Shandong Healsee Capsule
Anhui Huangshan Capsule
Farmacapsulas
Guangzhou Jiuzhou Capsule
Hunan Er-Kang Pharmaceutical
Hebei Kangxin Plant Capsule
Zhejiang Yueshan Capsule
Zhejiang Tianlong Capsule
Zhejiang Xinchang Kangping Capsule
Jiangsu Kangyoujian Biotechnology
Guizhou Guang De Li Pharmaceuticals
SUZHOU CAPSUGEL
Chongqing Heng Sheng Pharmaceutical
Jiangsu Youli Capsule
Jinan Gaohua Medicinal Capsule
Qingdao Gather Great Ocean Algae Industry Group
Segment by Type
00#
0#
1#
2#
3#
Others
Segment by Application
Pharmaceuticals
Health Supplements
Others
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
